AbbVie Total Liabilities & Equity increased by 0.0% to $133.96B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.9%, from $135.16B to $133.96B. Over 5 years (FY 2020 to FY 2025), Total Liabilities & Equity shows a downward trend with a -2.3% CAGR.
An increase typically reflects overall balance sheet growth or expansion of the company's asset base, while a decrease may indicate divestitures or debt repayment.
This represents the sum of all claims against a company's assets, combining obligations to external creditors and the re...
This is a standard accounting identity used across all industries to verify that assets equal the sum of liabilities and equity.
total_liabilities_and_equity| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $147.97B | $148.86B | $146.53B | $143.21B | $143.19B | $141.33B | $138.81B | $134.54B | $135.37B | $136.22B | $134.71B | $148.87B | $141.94B | $143.42B | $135.16B | $136.17B | $137.18B | $133.90B | $133.96B |
| QoQ Change | — | +0.6% | -1.6% | -2.3% | -0.0% | -1.3% | -1.8% | -3.1% | +0.6% | +0.6% | -1.1% | +10.5% | -4.7% | +1.0% | -5.8% | +0.7% | +0.7% | -2.4% | +0.0% |
| YoY Change | — | — | — | — | -3.2% | -5.1% | -5.3% | -6.1% | -5.5% | -3.6% | -2.9% | +10.7% | +4.9% | +5.3% | +0.3% | -8.5% | -3.4% | -6.6% | -0.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.